GlaxoSmithKline

• Ottawa announces influenza vaccine agreement with GlaxoSmithKline

  The deal includes an option to procure 80 million doses of influenza vaccine if a pandemic occurs and a minimum of four million doses annually.

  Health

  Jul 15, 2022
  
• Standard drugs used to fight COVID-19 may not work against Omicron: U.S. doctors

  The shrinking toolbox of treatments is a painful reminder that COVID-19 still has the upper hand in the U.S., even with more than 200 million Americans fully vaccinated.

  Health

  Dec 19, 2021
  
• Advertisement
• Sanofi’s COVID-19 vaccine sees up to 100% efficacy in latest trial

  The robust immune response results enable Sanofi and GlaxoSmithKline to move to a late-stage study, the French drugmaker said.

  World

  May 17, 2021
• Advertisement
• Canada’s Medicago begins late-stage study of COVID-19 vaccine with GlaxoSmithKline

  Medicago, which has Canada's most advanced COVID-19 vaccine project under development, expects to report results from a mid-stage trial of the vaccine in April.

  Canada

  Mar 16, 2021
• Drugmakers partner to develop COVID-19 vaccines aimed at new variants

  The announcement comes as public health officials around the world raise concerns about new virus variants that are more contagious or resistant to existing vaccines.

  World

  Feb 3, 2021
• Canada has approved 2 coronavirus vaccines. How are other candidates progressing?

  Here's where each of the vaccine candidates not yet approved by Health Canada currently stand in the development and review processes.

  Health

  Dec 24, 2020
• Two drugmakers say their coronavirus vaccine won’t be ready until late 2021

  "The results of the study are not as we hoped," Roger Connor, president of GSK Vaccines, said in a statement.

  World

  Dec 11, 2020
• Flu shot batch under review, Manitoba not reporting serious side effects

  A flu shot that was sent to Manitoba health-care providers is being shelved pending a safety review, but experts say it shouldn’t deter you from getting a shot this year.

  Health

  Nov 18, 2020
• Advertisement
• Trump to name former pharmaceutical exec to lead U.S. coronavirus vaccine push

  Moncef Slaoui, a former GlaxoSmithKline executive, will lead “Operation Warp Speed,” Trump’s push to accelerate the vaccine development process for COVID-19, according to an administration official.

  Health

  May 13, 2020
• Advertisement
• University of Saskatchewan professor to study marijuana as medicine

  University of Saskatchewan professor Robert Laprairie aims to gain more insight into the use of marijuana as a medicine.

  Health

  Nov 7, 2017